ArticleAngewandte Chemie (International ed. in English)2025
Degradation of Glyphosate to Benign N-Formyl Glycine Using MOF-808 Nanocrystals.
Article in Angewandte Chemie (International ed. in English), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Photocatalytic Upcycling of Toxic Glyphosate Waste Into Compound Fertilizer for Corn Growth.Advanced materials (Deerfield Beach, Fla.) · 2026Article
- Capacitively Coupled Alternating Electric Field for Accelerated and General Synthesis of Metal-Organic Frameworks.ACS central science · 2026Article
- Degradation of Glyphosate to Benign N-Formyl Glycine Using MOF-808 Nanocrystals.Angewandte Chemie (International ed. in English) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Glyphosate (N-phosphonomethyl glycine, GPh) is an industrial herbicide used worldwide in modern agricultural practices. With the growing concerns regarding cumulative environmental and health effects, pathways for catalytic GPh degradation to benign products are becoming a pressing societal need. This report demonstrates that Zr-based metal-organic framework (MOF-808) with different crystal sizes and designed defect sites can be employed as an efficient heterogeneous catalyst for the complete degradation of GPh at room temperature. Importantly, the degradation mechanism produces N-formyl glycine and hydroxymethyl-phosphonate, which are largely innocuous chemicals, especially when compared to more common GPh degradation products. Nanocrystalline MOF-808 (nMOF-808) exhibits enhanced reactivity than larger MOF-808 crystals, attributed to the higher coordination of hydroxyl and water molecules to the secondary building units (SBU) as determined using a range of X-ray absorption spectroscopy (XAS) techniques. These studies indicate that the crystal size-dependency in GPh degradation is related to structural modifications on coordinative unsaturated Zr site that promote the fast exchange of weakly bonded ligands. Taken together, this study demonstrates that GPh degradation can be optimized through ligand field tuning in MOFs, which can help improve overall reactivity while also pushing the reaction toward desirable, nontoxic products.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.